Mount Sinai’s Alon Harris, MS, PhD, FARVO, Receives Top Honor From The Glaucoma Foundation
Prestigious award recognizes significant contributions to the science
Alon Harris, MS, PhD, FARVO, Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai, has received the prestigious Robert Ritch Award for Innovation and Excellence in Glaucoma from The Glaucoma Foundation. He was presented with this honor on Friday, June 20, during the 29th Annual Glaucoma Foundation Scientific Think Tank in New York City.
This annual award, named in honor of the Foundation’s founder, recognizes the contributions of individuals who have played significant roles in promoting the science of glaucoma.
“I am incredibly humbled and honored to be presented with this prestigious award named after Dr. Ritch, especially considering the giants in the field who have received this recognition ahead of me,” says Dr. Harris. He is the Co-Director of the Barry Family Center for Ophthalmic Artificial Intelligence and Human Health, and Vice Chair of International Research and Academic Affairs, for the Department of Ophthalmology at the Icahn School of Medicine at Mount Sinai. “My research helped define the interaction between the cardiovascular system and eye disease, specifically as it relates to onset and progression of glaucoma. This award acknowledges the now-wide acceptance of blood flow and metabolism’s involvement in glaucoma following decades of dedicated focused research.”
Dr. Harris is an internationally recognized clinical research scientist focusing his work on glaucoma risk factor assessment, monitoring techniques for structural and functional glaucoma progression, ocular perfusion assessment, mathematical modeling and artificial intelligence, branded and generic glaucoma medications, novel imaging methodologies, and population-based studies. He has made significant contributions to the field of ophthalmology in the areas of vascular deficits in the fields of diabetic retinopathy, age-related macular degeneration, non-arteritic ischemic optic neuropathy, and brain physiology.
Dr. Harris is the third Mount Sinai clinical scientist to receive this honor. Louis R. Pasquale, MD, FARVO, Deputy Chair for Ophthalmology Research at the Icahn School of Medicine at Mount Sinai and Director of the Eye and Vision Research Institute at New York Eye and Ear Infirmary of Mount Sinai (NYEE), won the award in 2023. Robert Ritch, MD, who served as Chief of Glaucoma Services at NYEE, was the first to receive the award established in his name.
"Mount Sinai's Department of Ophthalmology extends our hearty congratulations to Professor Alon Harris on receiving this most distinguished award from The Glaucoma Foundation. He has made impactful research contributions to the field of glaucoma and is most deserving of this noteworthy recognition," said James C. Tsai, MD, MBA, President of NYEE and Chair of Ophthalmology for the Mount Sinai Health System.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across seven hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2024-2025.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube.